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Nitroxide-derived N-oxide phenazines for noncovalent spin-
labeling of DNA 
Haraldur Y. Juliusson[a] and Snorri Th. Sigurdsson*[a] 
Abstract: Two o-benzoquinone derivatives of isoindoline were 
synthesized for use as building blocks for incorporation of isoindoline 
nitroxides into different compounds and materials. These o-quinones 
were condensed with a number of o-phenylenediamines to form 
isoindoline-phenazines in high yields. Subsequent oxidation gave 
phenazine-di-N-oxide isoindoline nitroxides that were evaluated for 
noncovalent and site-directed spin-labeling of duplex DNA and RNA 
that contained abasic sites. While only minor binding was observed 
for RNA, the unsubstituted phenazine-N,N-dioxide tetramethyl 
isoindoline nitroxide showed high binding affinity and selectivity 
towards abasic sites in duplex DNA that contained cytosine as the 
orphan base. 
Introduction 
The field of radical chemistry has advanced considerably since 
the isolation and characterization of Fremy’s salt (1) (Figure 1), 
an inorganic compound containing a nitroxide, described in 
1845.[1] Over the years, the diversity of organic nitroxide radicals, 
a.k.a. aminoxyl radicals, has steadily increased. Of note is the 
synthesis of 2,2,6,6-tetramethyl-4-piperidone-1-oxyl (4-oxo-
TEMPO) (2) (Figure 1), described by Lebedev et al. in 1959.[2] 
The subsequent discovery of Rozantsev and Neiman that 
nitroxides can be involved in various organic reactions without 
affecting the aminoxyl group,[3] opened the door for the synthesis 
of numerous structurally diverse radicals.[4] Stable nitroxide 
radicals have been utilized in a variety of applications, such as 
antioxidants,[5] free radical scavengers,[6] stabilizers in the 
materials industry,[7] catalytic oxidizers[8] and site-directed spin 
labels.[9]  
 
Figure 1. Structures of common aminoxyl radicals: Fremy’s salt (1), 2,2,6,6-
tetramethyl-4-piperidone-1-oxyl (4-oxo-TEMPO) (2) and an isoindoline 
nitroxide (3). 
Isoindoline-based nitroxides (3) (Figure 1) have been the 
subject of much attention, because the fusion of the nitroxide-
containing ring to the aromatic ring provides rigidity and renders 
them resistant to ring opening reactions, which is a significant 
decomposition pathway for pyrrolidine and piperidine 
nitroxides.[10] Isoindoline-nitroxides also have narrower electron 
paramagnetic resonance (EPR) line widths,[11] and the aromatic 
ring, which can undergo a variety of substitution reactions, can 
be used to build more complex structures for a wide range of 
applications.  
Nitroxides have been used extensively as spin labels to study 
the structure and dynamics of biomolecules,[9] in particular 
nucleic acids and proteins. The term site-directed spin-labeling 
(SDSL) refers to the process of incorporation of a spin label at 
specific sites on diamagnetic biopolymers. For nucleic acid spin-
labeling, there are three main approaches, namely the 
phosphoramidite approach, post-synthetic labeling and 
noncovalent labeling. The first two methods rely on covalent 
attachment of the spin labels that usually require time-
consuming and non-trivial synthetic transformations. On the 
other hand, noncovalent spin-labeling utilizes binding through 
van der Waals interactions, hydrogen bonding and π-stacking. 
There are reports of spin-labeled intercalators and groove 
binders that bind to nucleic acids noncovalently, but most of 
them lack the sequence specificity that is usually required for 
EPR studies.[12] Noncovalent site-directed spin-labeling of the 
malachite green (MG) RNA aptamer has recently been reported, 
which utilized a spin-labeled derivative of tetramethylrosamine 
(TMR), and is the first example of site-specific spin labeling of a 
completely unmodified RNA.[13] Abasic sites in duplex nucleic 
acids have also been used as binding sites for noncovalent 
binding of small molecules. For example, fluorescent 
compounds that bind to abasic sites have been used for the 
detection of single nucleotide polymorphisms (SNPs).[14] An 
adenine acridine-derived spin-label has been used as an 
intercalator for noncovalent spin-labeling of a DNA duplex 
containing an abasic site.[15] The spin label ç, a cytosine-based 
spin label, bound specifically to abasic sites in duplex DNA 
opposite guanine (G).[16] The semi-flexible G-spin (Ǵ), a 
guanine-based spin label, was found to bind to abasic sites in 
duplex RNA opposite cytosine (C) with high affinity.[17] In spite of 
these advances, there is still demand for new methods for 
making different functionalized nitroxide radicals that might 
possess improved qualities for noncovalent spin-labeling, and 
other applications.  
Phenazines are an interesting class of compounds as they are 
redox-active and can therefore accept and donate electrons.[18] 
They are present in several natural products that are produced 
by Gram-positive and Gram-negative bacteria or by archaeal 
Methanosarcina species.[19] Phenazines display various 
interesting biologically-relevant functions[20] such as DNA-
intercalation,[20-21] inhibition of topoisomerases,[22] production of 
reactive oxygen species (ROS)[23] and radical scavenging.[24] 
Oxidized phenazines, phenazine-di-N-oxides (4) (Figure 2), 
have also been reported to be good intercalators into duplex 
DNA.[25] The synthesis of substituted phenazines presents a 
challenge since most of the synthetic methods that have been 
reported are low yielding and can tolerate a limited number of 
functional groups.[20] Early approaches of synthesizing 
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phenazines, such as the Wohl-Aue procedure[26] (1901) and the 
Bamberger-Ham reaction[27] (1911) were performed under harsh 
conditions, were low yielding and formed a significant number of 
byproducts. In the mid-1960s, Haddadin and coworkers reported 
the Beirut reaction[28] which addressed some of the limitations of 
phenazine substituents met in earlier procedures. The synthesis 
of phenazines through Pd-catalyzed coupling was reported in 
late 2000[29] and further improved in 2013 by Laha et al.[30] The 
condensation of o-phenylenediamines with o-benzoquinones, 
generated in situ from the corresponding catechols, has also 
been an important route that directly gives phenazines in 
moderate to high yields.[20,31]  
 
Figure 2. A structure of phenazine-di-N-oxide (4) and an isoindoline nitroxide-
derived phenazine-di-N-oxide (5). 
Here we describe the synthesis of o-benzoquinone derivatives of 
isoindoline that were condensed with a number of commercially 
available o-phenylenediamines to form isoindoline-phenazine 
skeletons. Oxidation of the isoindoline-phenazine moieties gave 
isoindoline-phenazine-N,N-dioxide nitroxide radicals, such as 5 
(Figure 2), that were evaluated for noncovalent spin-labeling of 
nucleic acids. Compound 5 showed extensive binding affinity 
and selectivity towards abasic sites in DNA. 
Results and Discussion 
The main incentive of this study was to prepare an isoindoline 
skeleton that would enable easy synthesis of structurally diverse 
nitroxide radicals, in particular by condensation with o-
phenylenediamines to create isoindoline-phenazine structures. 
We designed o-benzoquinone derivatives of both tetramethyl (6) 
and tetraethyl (7) isoindoline, as tetraethyl isoindoline nitroxides 
are more resistant to reduction,[32] for condensation with o-
phenylenediamines. 
 
Synthesis of o-quinone isoindolines 6 and 7 
The synthesis of 6 and 7 (Scheme 1) started with substitution of 
the bromines on tetramethylisoindoline 8[33] and 
tetraethylisoindoline 9[34] with methoxide to yield compounds 
10[35] and 11, respectively. Initial attempts to prepare o-quinone 
derivatives 6 and 7 from 10 and 11, respectively, by AgO and 
nitric acid-assisted oxidation[36] gave 6 and 7 only in very low 
yields. Therefore, dihydroxyl derivatives 12 and 13 were first 
prepared by demethylation of 10 and 11, respectively. Reactions 
of 10 and 11 with boron tribromide or iodotrimethylsilane, 
commonly used for demethylation of methyl ethers,[37] under a 
variety of conditions led to complex mixtures of products, which 
at best resulted in very low yields of 12 and 13. However, 
demethylation with iodotrimethylsilane, followed by a water-free 
workup and precipitation gave 12 and 13 in excellent yields. O-
quinones 6 and 7 were subsequently obtained in excellent yields 
by oxidation of 12 and 13 with MnO2 in the presence of air.[38] 
 
Scheme 1. Synthesis of o-quinone isoindolines 6 and 7. Yields were as 
follows: 10 (95%), 11 (62%), 12 (91%), 13 (77%), 6 (88%), 7 (93%). 
Condensation of 6 and 7 with o-phenylenediamines to give 
phenazines 
Several different conditions were evaluated for condensation of 
6 with o-phenylenediamine 14 (Table 1) to obtain 15. Most of 
the solvents that were evaluated resulted in moderate to 
excellent yields. Acetic acid (Table 1, entry 3) and EtOH (70% in 
H2O) (Table 1, entry 5) proved to be the best conditions. Using 
catalytic amount of a base led only to rapid decomposition of the 
diketones (Table 1, entry 6-8). In contrast, acetic acid was very 
effective as a catalyst. The optimal conditions proved to be 70% 
EtOH (aq.) with catalytic amount of acetic acid (Table 1, entry 
11).  




A number of commercially available o-phenylenediamines with 
different functional groups were condensed with o-
benzoquinones 6 and 7 to both investigate the scope of the 
condensation reaction and to create a small library of 
compounds for noncovalent spin-labeling (Table 2). All the 
selected o-phenylenediamines condensed readily with the 
diketones to give the desired products in near quantitative yields 
(>93%) (Table 2, entry 1-6), except for 24 (Table 2, entry 7) 
which did not give the desired product using any of the reaction 
conditions listed in Table 1. We postulate that the low solubility 
of 24 was the cause; low rate of condensation led to 
decomposition of o-quinones 6 and 7, both of which had limited 
stability in solution at room temperature (complete 
decomposition in 1-2 h). Compound 24 was soluble in DMSO 
but did not yield any condensed products upon incubation with 6 
(in the presence or absence of a catalytic amount of acetic acid). 
 
Phenazine-N-oxide derived nitroxides 
While oxidizing the phenazines with m-CPBA, it became 
apparent that the level of oxidation could be controlled by the 
number of equivalents of the oxidizing agent used in the reaction. 
When 15 was treated with one equivalent of m-CPBA, only 
nitroxide 26 was obtained (Scheme 2). The mono-N-oxide 
aminoxyl radical 27 was obtained with 2.2 eq. of the oxidizing 
agent and 5.5 eq. gave the di-N-oxide radical 5 (Scheme 2), all 
in very good to excellent yields.  
 Table 2.  Condensation of 6 and 7 with different derivatives of o-diamines. 
 
































For evaluating the isoindoline nitroxide-derived phenazines as 
noncovalent spin labels for duplex DNA and RNA containing 
abasic sites, the di-N-oxides were prepared, since 26 and 27 
had limited or no solubility in water. Oxidation of compounds 15, 
17, 19, 21 and 23 gave the desired phenazine di-N-oxide 
radicals 5 and 28-31 in very good yields (Table 3).  
 
Table 1.  Evaluation of reaction conditions for the synthesis of phenazine 
15 from o-quinone 6. 
 
No. Solvent Catalyst Time Yield (%) 
1 EtOH - 40 min 90 
2 CH2Cl2 - 60 min 70 
3 AcOH - <1 min 95 
4 CH3CN - 50 min 83 
5 70% EtOH - 30 min 94 
6 70% EtOH KOH <5 min 0 
7 EtOH Pyridine 10 min <1% 
8 EtOH Et3N 10 min <5% 
9 CH3CN AcOH 10 min 95 
10 CH2Cl2 AcOH 10 min 95 
11 70% EtOH AcOH <1 min 99 
12 EtOH AcOH 5 min 95 




Scheme 2. Reaction of phenazine 15 with different amounts of oxidizing 
agent. 
Since NMR spectra of the paramagnetic phenazine di-N-oxide 
nitroxides give limited information due to peak-broadening and 
even loss of NMR signals, UV-vis spectroscopy was used for 
spectroscopic characterization of the di-N-oxides (Figure S30), 
in addition to HRMS. Absorption peaks at 250 and 370 nm for 
the phenazine derivatives were red-shifted to 290 and 490 nm 
upon oxidation to the di-N-oxide radicals. The phenazine di-N-
oxide skeleton rendered the radicals water soluble to some 
extent, with the exception of the tetraethyl derivative 31, which 
made it possible to evaluate almost all as spin labels. 
 
Spin-labeling of abasic sites in duplex oligonucleotides 
Binding of 5, 28, 29 and 30 to abasic sites in DNA duplexes was 
evaluated by EPR spectroscopy.[16] Each spin label was 
incubated with a 14-mer duplex DNA containing an abasic site 
with either G, T, A or C as the orphan base at -30 °C (Figure 3). 
The EPR spectrum of each spin label in the absence of DNA 
(Figure 3, top row) showed comparatively narrow lines, 
consistent with fast tumbling of the radical in solution. In contrast, 
an EPR spectrum of a spin label bound to a DNA duplex is 
wider due to a longer rotational correlation time,[16] as observed 
for spin label 5, which showed high binding affinity and 
specificity towards abasic sites opposite to C (Figure 3, 
spectrum in upper box). Nitroxide 5 also showed nearly full 
binding (ca. 90%) opposite to A (Figure 3, spectrum in lower 
box), but a moderate to low binding opposite to T, represented 
by the mixture of slow- and fast-moving components in its EPR 
spectrum. Very little binding of 5 was observed to abasic sites 
opposite to G (<4%) or to an unmodified duplex (<2%) (see also 
Figure S31). Spin label 28 and 29 showed limited binding to 
abasic sites while 30 showed extensive binding to abasic sites 
opposite to all the nucleobases (C, A, G and T). However, 
substantial binding of 30 was also observed to the unmodified 
duplex to an extent of ca. 85% (Figure 3, bottom row to the 
right). The extensive nonspecific binding of 30 is most likely due 
to a large dipole moment, because of the nitro group, which 
facilitates intercalation.[39]   
Table 3. Oxidation of isoindoline-phenazines to the corresponding isoindoline-
phenazine di-N-oxide nitroxide radicals. 
 















Figure 3. Noncovalent spin labeling of abasic sites in DNA duplexes evaluated by EPR spectroscopy at -30 °C. EPR spectra of the labels without DNA (top row) 
and in the presence of unmodified DNA (bottom row) is shown for comparison. The central four rows show the spin labels in the presence of DNA duplexes 
containing an abasic site (denoted by “_”) opposite to the orphan bases G, T, A and C. Only a part of the DNA construct is shown to the left; the complete 
sequence is 5’-d(GACCTCG_ATCGTG)-3’·5’-d(CACGATXCGAGGTC)-3’, where X represents the orphan base. EPR spectra of the spin-labels (100 μM) in the 
presence of DNA duplexes (200 μM) were recorded in phosphate buffer (10 mM NaHPO4, 100 mM NaCl, 0.1 mM Na2EDTA, pH 7.0) containing 30% ethylene 
glycol and 2% DMSO at -30 °C. 
As spin label 5 exhibited full binding to abasic sites opposite to C 
and almost full binding opposite to A, the temperature 
dependence was investigated to obtain information about the 
relative affinity of the spin label to the abasic sites in question 
(Figure 4). Significant binding was already observed for the 
abasic site opposite to C at 0 °C, while close to no binding was 
seen for A, and almost full binding was observed at -20 °C 
(>95%). Little to no binding was observed at +10 °C and no 
binding was seen at +20 °C (data not shown). The dissociation 
constant (Kd) for 5 was determined to be 1.4 x 10-6 M at 0 °C by 
quantifying the amount of bound spin label from a doubly-
integrated EPR spectrum of 5 in the presence of the duplex 
containing the abasic site opposite C (see supporting 
information). Comparison with the binding affinity of the 
previously reported noncovalent spin labels Ǵ (Kd = 6.02 x 10-6 
M at 0 °C)[17b] and ç (Kd = 1.36 x 10-4 M at 0 °C)[16] to abasic 
sites in DNA opposite to C, shows that spin label 5 possesses 
higher affinity. The underlying structural reason behind the 
observed selectivity of 5 towards abasic sites opposite C (and to 
some extent A) was not obvious when we tried to model the 
label into an abasic site in duplex DNA. Although the abasic site 
is necessary for binding, one cannot rule out groove binding in 
the vicinity of the abasic site, as opposed to directly to the 
abasic site. Spin label 5 showed very minor binding to 14-mer 
duplex RNA containing an abasic site opposite to G, U, A or C at 
-30 °C (<3%, Figure S32), demonstrating its selectivity for DNA. 
In contrast, Ǵ shows extensive binding to abasic sites in RNA 
opposite C, even at +20 °C. The selectivity of 5 for abasic sites 
in DNA vs. RNA may originate in the narrower major groove of 
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RNA which may not be able to accommodate this relatively large 
label for binding to the abasic site. 
 
 
Figure 4. Evaluation of temperature-dependent noncovalent spin-labeling of 
spin label 5 to abasic sites in DNA duplexes opposite to A (middle column) 
and C (right column), by EPR spectroscopy. The EPR spectra of 5 alone and 
in the presence of an unmodified DNA at -30 °C are shown to the left. The 
EPR measurements were performed under the same conditions as listed in 
figure legend to Figure 3. 
Conclusion 
We have demonstrated the synthesis of o-benzoquinone 
derivatives for both tetramethyl- and tetraethyl-isoindoline that 
were readily condensed with a number of commercially available 
o-phenylenediamines in near quantitative yields. Oxidation of the 
isoindoline-phenazines gave phenazine di-N-oxide nitroxide 
radicals that were evaluated as noncovalent spin labels for DNA 
and RNA containing abasic sites. Spin label 5 showed high 
binding affinity and selectivity towards abasic sites opposite to C 
in DNA and is therefore a promising spin label for future EPR 
studies of DNAs. Moreover, the o-benzoquinone isoindoline 
derivatives 6 and 7 give access to various diversely substituted 
phenazine structures carrying the isoindoline moiety and thereby 
facilitate the incorporation of paramagnetic centers into other 
functional systems. 
Experimental Section 
General materials and methods. All commercially available reagents 
were purchased from Sigma-Aldrich co gmph or Acros Organics and 
used without further purification. CH2Cl2 was dried over calcium hydride 
and freshly distilled before use. All moisture- and air-sensitive reactions 
were carried out in oven-dried glassware under an inert atmosphere of Ar. 
Thin-layer chromatography (TLC) was performed using glass plates pre-
coated with silica gel (0.25 mm, F-25, Silicycle) and compounds were 
visualized under UV light and by p-anisaldehyde staining. Column 
chromatography was performed using 230–400 mesh silica gel (Silicycle). 
1H- and 13C-NMR spectra were recorded with a Bruker Avance 400 MHz 
spectrometer. Chemical shifts are reported in parts per million (ppm) 
relative to the partially deuterated NMR solvents CDCl3 (7.26 ppm for 1H 
NMR and 77.16 ppm for 13C) and CD3OD (3.35, 4.78 ppm for 1H NMR 
and 49.3 ppm for 13C). All coupling constants were measured in Hertz 
(Hz). Nitroxide radicals show broadening and loss of NMR signals due to 
their paramagnetic nature and therefore, those NMR spectra are not 
shown. Mass spectrometric analyses of all organic compounds were 
performed on an HRMS (ESI) (Bruker, MicrOTOF-Q) in positive ion mode.  
DNA and RNA synthesis and purifications. All commercial 
phosphoramidites, CPG columns, 5-ethylthiotetrazole and acetonitrile for 
oligomer synthesis were purchased from ChemGenes Corp., USA. All 
other required reagents and solvents were purchased from Sigma-Aldrich 
Co gmbh. Unmodified oligonucleotides and those containing abasic sites 
were synthesized on an automated ASM800 DNA synthesizer (Biosset, 
Russia) using a trityl-off protocol and commercially available 
phosphoramidites with standard protecting groups on a 1.0 μmole scale 
(1000 Å CPG columns). The DNA oligomers were deprotected in satd. 
NH3 at 55 °C for 8 h and dried in vacuo. The RNA oligomers were 
deprotected in a 1:1 solution (2 mL) of CH3NH2 (8 M in EtOH) and NH3 
(33% w/w in H2O) at 65 °C for 45 min. The solvent was removed in vacuo 
and the TBDMS-protecting groups were removed by incubation in 
NEt3:3HF (600 μL) for 90 min at 55 °C in DMF (200 μL), followed by 
addition of water (200 μL). This solution was transferred to a 50 mL 
Falcon tube, n-butanol (20 mL) was added and the mixture stored at 
−20 °C for 14 h, centrifuged at 4 °C and the solvent decanted from the 
RNA pellet. The oligonucleotides were purified by 20% denaturing 
polyacrylamide gel electrophoresis. The oligonucleotides were visualized 
by UV light and the bands were excised from the gel, crushed and 
extracted from the gel matrix with a Tris buffer (250 mM NaCl, 10 mM 
Tris, 1 mM Na2EDTA, pH 7.5). The extracts were filtered through 0.45 
μm, 25 mm diameter GD/X syringe filters (Whatman, USA) and desalted 
using Sep-Pak cartridges (Waters, USA), according to the manufacturer’s 
instructions. After removing the solvent in vacuo, the oligomers were 
dissolved in deionized and sterilized water (200 μL). Oligonucleotides 
were quantified using Beer’s law and measurements of absorbance at 
260 nm, using extinction coefficients determined by using the WinLab 
oligonucleotide calculator (V2.85.04, PerkinElmer). 
EPR measurements. Solutions for CW-EPR experiments were prepared 
by mixing aliquots of stock solutions of a single-stranded oligomer 
containing an abasic site, its complementary strand and the spin label in 
question (1:1.2:0.5). The solvent was evaporated in vacuo and the 
resulting residue was dissolved in phosphate buffer (10 μL; 10 mM 
NaHPO4, 100 mM NaCl, 0.1 mM Na2EDTA, pH 7.0) and annealed as 
followed: 90 °C for 2 min, 60 °C for 5 min, 50 °C for 5 min, 22 °C for 15 
min and dried using a SpeedVac. The residue was dissolved in an 
aqueous 30% ethylene glycol solution (10 μL) containing 2% DMSO and 
placed in a 50 μL quartz capillary (BLAUBRAND intraMARK) (final 
concentration of nucleic acid duplex 200 μM). The EPR spectra were 
recorded using 100-200 scans on a MiniScope MS200 (Magnettech 
Germany) spectrometer (100 kHz modulation frequency, 1.0 G 
modulation amplitude and 2.0 mW microwave power). A magnettech 
temperature controller M01 (± 0.5 °C) was used as temperature regulator.  
5,6-Dimethoxy-1,1,3,3-tetramethylisoindoline (10). A solution of 8 (350 
mg, 1.05 mmol) in DMF (1.5 mL) was added to a stirred solution of 
NaOMe in MeOH (5 M, 2 mL). Copper iodide (60 mg, 0.3 mmol) was 
added and the mixture heated at 145 °C for 29 h. The reaction mixture 
was cooled to room temperature, poured onto ice and extracted with 
Et2O (3 x 30 mL). The combined organic phases were washed with H2O 
(2 x 30 mL) and brine (3 x 30 mL), dried over Na2SO4 and concentrated 
in vacuo to yield 10 (160 mg, 95%) as a brown-orange solid, which was 
directly used for the next step without further purification. 1H-NMR (400 
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MHz, CDCl3): δ = 6.62 (s, 2H), 3.90 (s, 6H), 1.45 (s, 12H). 13C-NMR (101 
MHz, CDCl3): δ = 148.9, 140.3, 104.5, 62.8, 56.5, 32.0. HRMS (ESI) m/z 
[M+H]+ calcd for C14H22NO2+: 236.1645;  found 236.1632. 
1,1,3,3-Tetramethylisoindoline-5,6-diol (12). A solution of 10 (100 mg, 
0.425 mmol) in CH2Cl2 (5 mL) was treated with iodotrimethylsilane (0.2 
mL, 1.40 mmol) at 0 °C and the reaction mixture was stirred at 22 °C for 
72 h. MeOH (10 mL) was added and the solution was stirred for 1 h and 
concentrated in vacuo to yield a black oily residue that subsequently 
solidified. The black residue was dissolved in a minimum amount of 
MeOH (1 mL) followed by a slow addition of CH2Cl2 (20 mL) to yield a 
gray precipitate. The solid was filtered and washed with cold CH2Cl2 to 
yield 12 (80 mg, 91%) as a white solid. 1H-NMR (400 MHz, CD3OD): δ = 
6.72 (s, 2H), 1.67 (s, 12H). 13C-NMR (101 MHz, CD3OD) δ = 148.7, 
131.0, 109.3, 77.1, 25.5. HRMS (ESI) m/z [M+H]+ calcd for C12H18NO2+: 
208.1332;  found 208.1336. 
1,1,3,3-Tetramethylisoindoline-5,6-dione (6). A solution of 12 (25 mg, 
0.12 mmol) in MeOH (0.5 mL) was added to a stirred solution of MnO2 
(1.0 g) in CH2Cl2 (20 mL) and the resulting mixture stirred at 22 °C for 3 h. 
The reaction mixture was filtered through a Büchner funnel, MnO2 was 
recovered, the filtrate was concentrated in vacuo and the residue purified 
by flash-column chromatography, using a gradient elution (CH2Cl2/MeOH, 
100:0 to 90:10), to yield 6 (22 mg, 88 %) as a dark brown solid. 1H-NMR 
(400 MHz, CDCl3): δ = 6.17 (s, 2H), 1.44 (s, 12H). 13C-NMR (101 MHz, 
CDCl3): δ = 178.7, 167.3, 120.8, 70.6, 60.6, 31.6, 30.6, 29.7, 27.5. HRMS 
(ESI) m/z [M+H]+ calcd for C12H16NO2+: 206.1176;  found 206.1172. 
1,1,3,3-Tetraethyl-5,6-dimethoxyisoindoline (11). A solution of 9 (350 
mg, 0.90 mmol) in anhydrous DMF (1.5 mL) was added to a stirred 
solution of NaOMe in MeOH (5 M, 2 mL). Copper iodide (60 mg, 0.3 
mmol) was added and the mixture was heated at 145 °C for 29 h. The 
reaction mixture was cooled to room temperature, poured onto ice and 
extracted with Et2O (3 x 30 mL). The combined organic phases were 
washed with H2O (2 x 30 mL) and brine (3 x 30 mL), dried over Na2SO4 
and concentrated in vacuo to yield 11 (160 mg, 62%) as a brown-orange 
solid, which was directly used for the next step without further purification. 
1H-NMR (400 MHz, CDCl3) δ = 6.56 (s, 2H), 3.87 (s, 6H), 1.75 – 1.57 (m, 
8H), 0.88 (t, J = 7.5 Hz, 12H). 
1,1,3,3-Tetraethylisoindoline-5,6-diol (13). A solution of 11 (160 mg, 
0.552 mmol) in CH2Cl2 (5 mL) was treated with iodotrimethylsilane (0.26 
mL, 1.82 mmol) at 0 °C and the solution was stirred at 22 °C for 72 h. 
MeOH (10 mL) was added and the solution stirred for 1 h and 
concentrated in vacuo to yield a black oily residue that subsequently 
solidified. The black residue was dissolved in minimum amount of MeOH 
(1 mL) followed by a slow addition of CH2Cl2 (20 mL) to yield a gray 
precipitate. The solid was filtered and washed with cold CH2Cl2 to yield 
13 (112 mg, 77%) as a white solid. 1H-NMR (400 MHz, CD3OD): δ = 6.64 
(s, 2H), 2.04 (q, J = 7.4 Hz, 8H), 1.03 (t, J = 7.4 Hz, 12H). 13C-NMR (101 
MHz, CD3OD): δ = 147.9, 132.2, 110.7, 76.8, 31.7, 8.7. HRMS (ESI) m/z 
[M+H]+ calcd for C16H26NO2+: 264.1958;  found 264.1948. 
1,1,3,3-Tetraethylisoindoline-5,6-dione (7). A solution of 13 (27 mg, 
0.10 mmol) in MeOH (0.5 mL) was added to a stirred solution of MnO2 
(1000 mg) in CH2Cl2 (20 mL) and the resulting mixture stirred for 3 h at 
room temperature. The reaction mixture was filtered through a Büchner 
funnel, MnO2 was recovered, the filtrate was concentrated in vacuo and 
the residue purified by flash-column chromatography (CH2Cl2 100%), to 
yield 7 (25 mg, 93 %) as a dark brown solid. 1H-NMR (400 MHz, CDCl3): 
δ = 6.10 (s, 2H), 1.65 (qd, J = 14.1, 7.3 Hz, 8H), 0.93 (t, J = 7.4 Hz, 12H). 
13C-NMR (101 MHz, CDCl3): δ = 178.8, 166.4, 121.6, 66.5, 32.9, 8.5. 
HRMS (ESI) m/z [M+H]+ calcd for C16H24NO2+: 262.1802;  found 
262.1801. 
Isoindoline phenazine 15. To a solution of 70% EtOH in H2O (4 mL) 
containing 1 drop of AcOH was added 6 (98.4 mg, 0.48 mmol) and 14 
(73.5 mg, 0.48 mmol) and the solution was stirred at 22 °C for 30 min. 
The solvent was removed in vacuo and the residue purified by flash-
column chromatography, using a gradient elution (CH2Cl2/MeOH, 100:0 
to 90:10), to yield 15 (131.8 mg, 99 %) as a yellowish solid. 1H-NMR (400 
MHz, CDCl3): δ = 8.11 (dd, J = 6.7, 3.4 Hz, 2H), 7.85 (s, 2H), 7.69 (dd, J 
= 6.7, 3.4 Hz, 2H), 1.53 (s, 13H). 13C-NMR (101 MHz, CDCl3) δ = 154.95, 
142.95, 130.03, 129.43, 120.76, 103.38, 62.29, 32.11. HRMS (ESI) m/z 
[M+H]+ calcd for C18H20N3+: 278.1652;  found 278.1633. 
Bromo isoindoline phenazine 17. To a solution of 70% EtOH in H2O 
(2.5 mL) containing 1 drop of AcOH was added 6 (16.4 mg, 0.079 mmol) 
and 16 (14.9 mg, 0.079 mmol) and the solution was stirred at 22 °C for 
30 min. The solvent was removed in vacuo and the residue purified by 
flash-column chromatography, using a gradient elution (CH2Cl2/MeOH, 
100:0 to 90:10), to yield 17 (26.7 mg, 95 %) as a brownish-yellow solid. 
1H-NMR (400 MHz, CDCl3): δ = 8.41 (d, J = 2.0 Hz, 1H), 8.07 (d, J = 9.2 
Hz, 1H), 7.92 (s, 2H), 7.85 (dd, J = 9.2, 2.1 Hz, 1H), 1.67 – 1.59 (m, 13H). 
13C-NMR (101 MHz, CDCl3): δ = 155.9, 155.5, 143.8, 143.5, 143.2, 141.6, 
133.8, 131.5, 130.7, 124.5, 121.0, 120.9, 62.5, 32.1, 29.7. HRMS (ESI) 
m/z [M+H]+ calcd for C18H19BrN3+: 356.0757;  found 356.0757. 
Dichloro isoindoline phenazine 19. To a solution of 70% EtOH in H2O 
(2.5 mL) containing 1 drop of AcOH was added 6 (12.0 mg, 0.058 mmol) 
and 18 (10.3 mg, 0.058 mmol) and the solution was stirred at 22 °C for 
30 min. The solvent was removed in vacuo and the residue purified by 
flash-column chromatography, using a gradient elution (CH2Cl2/MeOH, 
100:0 to 90:10), to yield 19 (19.1 mg, 95 %) as a brownish yellow solid.  
1H-NMR (400 MHz, CDCl3) δ = 8.35 (s, 2H), 7.91 (s, 2H), 1.65 (s, 12H). 
13C-NMR (101 MHz, CDCl3): δ = 144.0, 141.6, 129.8, 121.1, 117.6, 77.5, 
77.2, 76.8, 62.7, 32.1, 29.8. HRMS (ESI) m/z [M+H]+ calcd for 
C18H18Cl2N3+: 346.0872;  found 346.0862. 
Nitro isoindoline phenazine 21. To a solution of 70% EtOH in H2O (4 
mL) containing 1 drop of AcOH was added 6 (24.4 mg, 0.12 mmol) and 
20 (18.2 mg, 0.12 mmol) and the solution was stirred at 22 °C for 30 min. 
The solvent was removed in vacuo and the residue purified by flash-
column chromatography, using a gradient elution (CH2Cl2/MeOH, 100:0 
to 90:10), to yield 21 (35.7 mg, 93 %) as a bright yellow solid. 1H-NMR 
(400 MHz, CDCl3): δ = 9.16 (d, J = 2.2 Hz, 1H), 8.54 (dd, J = 9.5, 2.5 Hz, 
1H), 8.36 (d, J = 9.5 Hz, 1H), 7.99 (d, J = 6.1 Hz, 2H), 1.69 (d, J = 2.0 Hz, 
12H). 13C-NMR (101 MHz, CDCl3): δ = 147.9, 144.9, 144.3, 141.2, 131.4, 
126.6, 123.0, 121.3, 121.2, 62.8, 32.0, 29.8. HRMS (ESI) m/z [M+H]+ 
calcd for C18H19N4O2+: 323.1503;  found 323.1501. 
Ethylnitro isoindoline phenazine 22. To a solution of 70% EtOH in H2O 
(2.5 mL) containing 1 drop of AcOH was added 7 (50 mg, 0.191 mmol) 
and 20 (29.3 mg, 0.191 mmol) and the solution was stirred at 22 °C for 
30 min. The solvent was removed in vacuo and the residue purified by 
flash-column chromatography, using a gradient elution (CH2Cl2/MeOH, 
100:0 to 95:5), to yield 22 (65.2 mg, 90 %) as a brownish yellow solid.  
1H-NMR (400 MHz, CDCl3) δ 9.17 (d, J = 2.4 Hz, 1H), 8.53 (d, J = 2.5 Hz, 
1H), 8.35 (d, J = 9.5 Hz, 1H), 7.93 (d, J = 5.4 Hz, 2H), 1.97 – 1.79 (m, 
8H), 0.98 (td, J = 7.4, 1.5 Hz, 12H). 13C-NMR (101 MHz, CDCl3) δ = 
155.9, 154.9, 146.8, 143.8, 143.7, 143.2, 140.0, 130.3, 125.5, 121.8, 
120.9, 120.7, 67.2, 67.1, 33.0, 28.7, 7.9, 0.0. HRMS (ESI) m/z [M+H]+ 
calcd for C22H27N4O2+: 379.2129;  found 379.2126. 
Ethylbromo isoindoline phenazine 23. To a solution of 70% EtOH in 
H2O (2.5 mL) containing 1 drop of AcOH was added 7 (12.6 mg, 0.048 
mmol) and 16 (8.9 mg, 0.048 mmol) and the solution was stirred at 22 °C 
for 30 min. The solvent was removed in vacuo and the residue purified by 
flash-column chromatography, using a gradient elution (CH2Cl2/ MeOH, 
100:0 to 95:5), to yield 23 (19 mg, 96 %) as a brownish-yellow solid. 1H-
NMR (400 MHz, CDCl3): δ = 8.41 (d, J = 2.1 Hz, 1H), 8.07 (d, J = 9.2 Hz, 
1H), 7.87 (s, 2H), 7.85 (dd, J = 9.2, 2.1 Hz, 1H), 1.95 – 1.77 (m, 9H), 0.97 
(t, J = 7.4 Hz, 13H). 13C-NMR (101 MHz, CDCl3) δ = 142.6, 142.4, 142.1, 
140.5, 132.7, 130.4, 129.7, 123.2, 120.7, 120.6, 67.0, 33.0, 7.7, 0.0. 
HRMS (ESI) m/z [M+H]+ calcd for C22H27BrN3+: 412.1383;  found 
412.1383. 
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Isoindoline phenazine radical 26. To a solution of 15 (10 mg, 0.036 
mmol) in CH2Cl2 (2 mL), was added m-chloroperoxybenzoic acid (6.2 mg, 
0.036 mmol) and the resulting solution stirred at 22 °C for 12 h in a 
closed reaction vial. The solution was poured onto ice, extracted with 
CH2Cl2 (3 x 10 mL), dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by preparative TLC (CH2Cl2/MeOH; 95:5) to 
yield 26 (9.4 mg, 89% yield) as a yellow solid. HRMS (ESI) m/z [M+Na]+ 
calcd for C18H18N3O+: 315.1348;  found 315.1308. 
Dioxidized isoindoline phenazine 27. To a solution of 15 (10 mg, 0.036 
mmol) in CH2Cl2 (2 mL), was added m-chloroperoxybenzoic acid (13.6 
mg, 0.079 mmol) and the resulting solution stirred at 22 °C for 12 h in a 
closed reaction vial. The solution was poured onto ice, extracted with 
CH2Cl2 (3 x 10 mL), dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by preparative TLC (CH2Cl2/MeOH; 95:5) to 
yield 27 (7.8 mg, 70% yield) as an orange-red solid. HRMS (ESI) m/z 
[M+Na]+ calcd for C18H18N3O2+: 331.1297;  found 331.1286. 
Trioxidized isoindoline phenazine 5. To a solution of 15 (10 mg, 0.036 
mmol) in CH2Cl2 (2 mL), was added m-chloroperoxybenzoic acid (34.2 
mg, 0.198 mmol) and the resulting solution stirred at 22 °C for 12 h in a 
closed reaction vial. The solution was poured onto ice, extracted with 
CH2Cl2 (3 x 10 mL), dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by preparative TLC (CH2Cl2/MeOH; 95:5) to 
yield 5 (9 mg, 77% yield) as a bright red solid. HRMS (ESI) m/z [M+Na]+ 
calcd for C18H18N3O3+: 347.1240;  found 347.1215. 
Trioxidized bromo isoindoline phenazine 28. To a solution of 17 (10 
mg, 0.028 mmol) in CH2Cl2 (2 mL), was added m-chloroperoxybenzoic 
acid (26.6 mg, 0.154 mmol) and the resulting solution stirred at 22 °C for 
12 h in a closed reaction vial. The solution was poured onto ice, 
extracted with CH2Cl2 (3 x 10 mL), dried over Na2SO4 and concentrated 
in vacuo. The crude product was purified by preparative TLC 
(CH2Cl2/MeOH; 95:5) to yield 28 (8.1 mg, 72% yield) as a deep brown-
red solid. HRMS (ESI) m/z [M+Na]+ calcd for C18H17N3O3Br+: 425.0345;  
found 425.0360. 
Trioxidized dichloro isoindoline phenazine 29. To a solution of 19 (10 
mg, 0.029 mmol) in CH2Cl2 (2 mL), was added m-chloroperoxybenzoic 
acid (26.6 mg, 0.154 mmol) and the resulting solution stirred at 22 °C for 
12 h in a closed reaction vial. The solution was poured onto ice, 
extracted with CH2Cl2 (3 x 10 mL), dried over Na2SO4 and concentrated 
in vacuo. The crude product was purified by preparative TLC 
(CH2Cl2/MeOH; 95:5) to yield 29 (7.9 mg, 70% yield) as a brownish solid. 
HRMS (ESI) m/z [M+H]+ calcd for C18H17N3O3Cl2+: 393.0641;  found 
393.0556. 
Trioxidized nitro isoindoline phenazine 30. To a solution of 21 (10 mg, 
0.031 mmol) in CH2Cl2 (2 mL), was added m-chloroperoxybenzoic acid 
(29.4 mg, 0.171 mmol) and the resulting solution stirred at 22°C for 12 h 
in a closed reaction vial. The solution was poured onto ice, extracted with 
CH2Cl2 (3 x 10 mL), dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by preparative TLC (CH2Cl2/MeOH; 95:5) to 
yield 30 (8.9 mg, 78% yield) as a bright red solid. 
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